The Division of Clinical Neurooncology focuses on experimental therapy for malignant glioma, i.e. glioblastoma, anaplastic glioma and gliomatosis cerebri, but trials are also open for brain metastasis, primary CNS lymphoma, primary and recurrent medulloblastoma. Most trials are associated with translational research programs to study molecular and cellular signatures associated with outcome. The Division of Clinical Neurooncology is participating in basic and translational research projects coordinated by the Experimental and Translational Neurooncology.